{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:17:38Z","timestamp":1792192658580,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1999,3,1]],"date-time":"1999-03-01T00:00:00Z","timestamp":920246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[1999,3]]},"DOI":"10.1006\/taap.1998.8582","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T22:01:25Z","timestamp":1032386485000},"page":"227-236","source":"Crossref","is-referenced-by-count":10,"title":["Atypical Antipsychotic-Induced Neutropenia in Dogs"],"prefix":"10.1006","volume":"155","author":[{"given":"Meike","family":"Lorenz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winston E.","family":"Evering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Provencher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia T.","family":"Blue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh B.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff R.","family":"Hazelette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parthasarathi","family":"Rajagopalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C.","family":"Meunier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D.","family":"Car","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/taap.1998.8582_RF1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1192\/bjp.169.4.483","article-title":"Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland","volume":"169","author":"Atkin","year":"1996","journal-title":"Br. J. Psychiatry"},{"key":"10.1006\/taap.1998.8582_RF2","first-page":"746","article-title":"Clozapine: A novel antipsychotic agent","volume":"234","author":"Baldessarini","year":"1991","journal-title":"N. Engl. J. Med"},{"key":"10.1006\/taap.1998.8582_RF3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0024-3205(93)90645-J","article-title":"Uptake and biodistribution of dopamine in bone marrow, spleen and lymph nodes of normal and tumor bearing mice","volume":"53","author":"Basu","year":"1993","journal-title":"Life Sci."},{"key":"10.1006\/taap.1998.8582_RF4","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2125.1994.tb04385.x","article-title":"Clozapine disposition covaries with activity determined by a caffeine test","volume":"38","author":"Bertilson","year":"1994","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1006\/taap.1998.8582_RF5","series-title":"The Merck Index","author":"Buvadari","year":"1996"},{"key":"10.1006\/taap.1998.8582_RF6","first-page":"55","article-title":"The relationship of pharmacology to side effects","volume":"58","author":"Casey","year":"1997","journal-title":"J. Clin. Psychiatry"},{"key":"10.1006\/taap.1998.8582_RF7","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/070674379604100504","article-title":"Use of cytokines in clozapine-induced agranulocytosis","volume":"41","author":"Chin-Yee","year":"1996","journal-title":"Can. J. Psychiatry"},{"key":"10.1006\/taap.1998.8582_RF8","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1182\/blood.V86.10.3835.bloodjournal86103835","article-title":"The major histocompatibility complex region marked by HSP70\u20131 and HSP70\u20132 variants is associated with clozapine-induced agranulocytosis in two different ethnic groups","volume":"86","author":"Corzo","year":"1995","journal-title":"Blood"},{"key":"10.1006\/taap.1998.8582_RF9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/019262339302100216","article-title":"Development and application ofin vitro","volume":"21","author":"Deldar","year":"1993","journal-title":"Toxicol. Pathol."},{"key":"10.1006\/taap.1998.8582_RF10","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/stem.5530090608","article-title":"Canine BFU-e progenitors: Adaptation of a reproducible assay and anatomical distribution","volume":"9","author":"Deldar","year":"1991","journal-title":"Int. J. Cell Cloning"},{"key":"10.1006\/taap.1998.8582_RF11","first-page":"846","article-title":"Possible role of free radical formation in clozapine (clozaril)-induced agranulocytosis","volume":"40","author":"Fischer","year":"1991","journal-title":"Mol. Pharmacol."},{"key":"10.1006\/taap.1998.8582_RF12","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/00004714-199712000-00014","article-title":"Prolongation of clozapine-induced granulocytopenia associated with olanzapine","volume":"17","author":"Flynn","year":"1997","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1006\/taap.1998.8582_RF13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00606409","article-title":"Agranulocytosis during treatment with clozapine","volume":"11","author":"Idanpaan-Heikkila","year":"1977","journal-title":"Eur. J. Clin. Pharmacol"},{"key":"10.1006\/taap.1998.8582_RF14","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.4049\/jimmunol.142.7.2332","article-title":"Net increase of pluripotential hematopoietic precursors in suspension culture in response to IL-1 and IL-3","volume":"142","author":"Iscove","year":"1989","journal-title":"J. Immunol."},{"key":"10.1006\/taap.1998.8582_RF15","series-title":"Schalm's Veterinary Hematology","author":"Jain","year":"1986"},{"key":"10.1006\/taap.1998.8582_RF16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/j.1875-9114.1991.tb02628.x","article-title":"Clozapine","volume":"11","author":"Jann","year":"1991","journal-title":"Pharmacotherapy"},{"key":"10.1006\/taap.1998.8582_RF17","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1182\/blood.V72.6.1875.1875","article-title":"In vivo","volume":"72","author":"Johnson","year":"1988","journal-title":"Blood"},{"key":"10.1006\/taap.1998.8582_RF18","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1006\/taap.1998.8582_RF19","series-title":"Casarett and Doull's Toxicology: The Basic Science of Poisons","article-title":"Principles of Toxicology","author":"Klaassen","year":"1991"},{"key":"10.1006\/taap.1998.8582_RF20","first-page":"271","article-title":"Clozapine-induced agranulocytosis: Non cross-reactivity with other psychotropic drugs","volume":"49","author":"Lieberman","year":"1988","journal-title":"J. Clin. Psychiatry"},{"key":"10.1006\/taap.1998.8582_RF21","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1192\/bjp.158.4.503","article-title":"The effect of clozapine on tardive dyskinesia","volume":"158","author":"Lieberman","year":"1991","journal-title":"Br. J. Psychiatry"},{"key":"10.1006\/taap.1998.8582_RF22","first-page":"1476","article-title":"Clozapine is oxidized by activated human neutrophils to a reactive nitrenium ion that irreversibly binds to the cells","volume":"275","author":"Liu","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1006\/taap.1998.8582_RF23","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1182\/blood.V80.5.1178.1178","article-title":"Effect of adrenergic agents on hematopoieis after syngeneic bone marrow transplantation in mice","volume":"80","author":"Maestroni","year":"1992","journal-title":"Blood"},{"key":"10.1006\/taap.1998.8582_RF24","first-page":"1463","article-title":"The metabolic formation of reactive intermediates from clozapine, a drug-associated with agranulocytosis in man","volume":"275","author":"Maggs","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1006\/taap.1998.8582_RF25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2165\/00002018-199200071-00010","article-title":"Possible role of free radical formation in drug-induced agranulocytosis","volume":"7","author":"Mason","year":"1992","journal-title":"Drug Safety"},{"key":"10.1006\/taap.1998.8582_RF26","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1176\/ajp.136.12.1550","article-title":"Effect of clozapine on human serum prolactin levels","volume":"136","author":"Meltzer","year":"1979","journal-title":"Am. J. Psychiatry"},{"key":"10.1006\/taap.1998.8582_RF27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1042\/bst0190183","article-title":"Immune haemolytic anaemia and thrombocytopenia with drugs and antibodies","volume":"19","author":"Murphy","year":"1991","journal-title":"Biochem. Soc. Trans."},{"key":"10.1006\/taap.1998.8582_RF28","doi-asserted-by":"crossref","first-page":"895","DOI":"10.2165\/00003495-199651060-00001","article-title":"Adverse effects of antipsychotic agents. Do newer agents offer advantages?","volume":"51","author":"Owens","year":"1996","journal-title":"Drugs"},{"key":"10.1006\/taap.1998.8582_RF29","first-page":"984","article-title":"Metabolism and bio-activation of clozapine by human liverin vitro","volume":"272","author":"Pirmohamed","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1006\/taap.1998.8582_RF30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00003088-199631030-00005","article-title":"Idiosyncratic drug reactions","volume":"31","author":"Pirmohamed","year":"1996","journal-title":"Clin. Pharmacokinet."},{"key":"10.1006\/taap.1998.8582_RF31","article-title":"The cytoimmune mechanism and predictability of clozapine-induced agranulocytosis","volume":"72","author":"Pisciotta","year":"1988","journal-title":"Blood"},{"key":"10.1006\/taap.1998.8582_RF32","first-page":"254","article-title":"Cytotoxic activity in serum with clozapine-induced agranulocytosis","volume":"119","author":"Pisciotta","year":"1992","journal-title":"J. Lab. Clin. Med."},{"key":"10.1006\/taap.1998.8582_RF33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00002018-199200071-00009","article-title":"On the possible mechanisms and predictability of clozapine-induced agranulocytosis","volume":"7","author":"Pisciotta","year":"1992","journal-title":"Drug Safety"},{"key":"10.1006\/taap.1998.8582_RF34","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00004714-199610000-00011","article-title":"Effects of clozapine on plasma cytokine and soluble cytokine receptor levels","volume":"16","author":"Pollmacher","year":"1996","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1006\/taap.1998.8582_RF35","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/archpsyc.1995.03950220087016","article-title":"Clozapine-induced increase in plasma soluble interleukin-2 receptors","volume":"52","author":"Pollmacher","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1006\/taap.1998.8582_RF36","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1182\/blood.V81.6.1497.1497","article-title":"The use of 5-fluorouracil to analyze the effect of macrophage inflammatory protein-1\u03b1 on long-term reconstituting stem cellsin vivo","volume":"81","author":"Quesniaux","year":"1993","journal-title":"Blood"},{"key":"10.1006\/taap.1998.8582_RF37","first-page":"475","article-title":"Dopamine inhibitors tumor growth and concomitantly stimulated erythrocyte and platelet production in experimental tumor bearing mice","volume":"5","author":"Ray","year":"1988","journal-title":"Biog. Amine"},{"key":"10.1006\/taap.1998.8582_RF38","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1182\/blood.V69.1.165.165","article-title":"Canine pluripotent hemopoietic stem cells and CFU-GM express Ia-like antigens as recognized by two different class-II specific monoclonal antibodies","volume":"69","author":"Schuening","year":"1987","journal-title":"Blood"},{"key":"10.1006\/taap.1998.8582_RF39","series-title":"Casarett and Doull's Toxicology: The Basic Science of Poisons","first-page":"257","article-title":"Toxic responses of the blood","author":"Smith","year":"1991"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X98985829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X98985829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T04:41:04Z","timestamp":1703911264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X98985829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1999,3]]}},"alternative-id":["S0041008X98985829"],"URL":"https:\/\/doi.org\/10.1006\/taap.1998.8582","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[1999,3]]}}}